Clinical Trial Update: CD19-CART Treatment for ALL [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial update for a CD19-CART treatment in acute leukemia has completed enrollment and status updated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• CD19-CART treatment

Snippet

Sponsor: Bioray Laboratories | Conditions: Acute Leukemia | Phase 1, Phase 2 | Status: COMPLETED